ATE312946T1 - Verfahren und vorrichtung zur bestimmung der gewebespezifität von freier dna in körperflüssigkeiten - Google Patents
Verfahren und vorrichtung zur bestimmung der gewebespezifität von freier dna in körperflüssigkeitenInfo
- Publication number
- ATE312946T1 ATE312946T1 AT02004954T AT02004954T ATE312946T1 AT E312946 T1 ATE312946 T1 AT E312946T1 AT 02004954 T AT02004954 T AT 02004954T AT 02004954 T AT02004954 T AT 02004954T AT E312946 T1 ATE312946 T1 AT E312946T1
- Authority
- AT
- Austria
- Prior art keywords
- determining
- amount
- free floating
- dna
- floating dna
- Prior art date
Links
- 210000001124 body fluid Anatomy 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000010839 body fluid Substances 0.000 title 1
- 210000000056 organ Anatomy 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000011987 methylation Effects 0.000 abstract 1
- 238000007069 methylation reaction Methods 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 230000002062 proliferating effect Effects 0.000 abstract 1
- 210000003296 saliva Anatomy 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
- 210000002700 urine Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02004954A EP1342794B1 (de) | 2002-03-05 | 2002-03-05 | Verfahren und Vorrichtung zur Bestimmung der Gewebespezifität von freier DNA in Körperflüssigkeiten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE312946T1 true ATE312946T1 (de) | 2005-12-15 |
Family
ID=27741132
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02004954T ATE312946T1 (de) | 2002-03-05 | 2002-03-05 | Verfahren und vorrichtung zur bestimmung der gewebespezifität von freier dna in körperflüssigkeiten |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20050221314A1 (de) |
| EP (2) | EP1342794B1 (de) |
| JP (1) | JP4727149B2 (de) |
| AT (1) | ATE312946T1 (de) |
| AU (1) | AU2003218691B2 (de) |
| CA (1) | CA2478493A1 (de) |
| DE (1) | DE60207979T2 (de) |
| DK (1) | DK1342794T3 (de) |
| ES (1) | ES2253461T3 (de) |
| WO (1) | WO2003074730A1 (de) |
Families Citing this family (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060183128A1 (en) * | 2003-08-12 | 2006-08-17 | Epigenomics Ag | Methods and compositions for differentiating tissues for cell types using epigenetic markers |
| DE10348407A1 (de) * | 2003-10-17 | 2005-05-19 | Widschwendter, Martin, Prof. | Prognostische und diagnostische Marker für Zell-proliferative Erkrankungen von Brustgeweben |
| EP3095878A1 (de) * | 2005-11-17 | 2016-11-23 | Epigenomics AG | Verfahren zur bestimmung des dna-methylierungsgrads einer cpg-position in identischen zellen in einer gewebeprobe |
| WO2008090930A1 (ja) * | 2007-01-23 | 2008-07-31 | Olympus Corporation | 癌の診断方法 |
| JP5378687B2 (ja) | 2007-03-02 | 2013-12-25 | エフ．ホフマン−ラ ロシュ アーゲー | Ｂａｓｐ１遺伝子および／またはｓｒｄ５ａ２遺伝子中のメチル化シトシンを利用する、肝臓癌、肝臓癌発症リスク、肝臓癌再発リスク、肝臓癌悪性度および肝臓癌の経時的進展の検出方法 |
| WO2009003654A2 (en) * | 2007-06-29 | 2009-01-08 | Medizinische Universität Innsbruck | Selecting nucleic acid samples suitable for genotyping |
| US12180549B2 (en) | 2007-07-23 | 2024-12-31 | The Chinese University Of Hong Kong | Diagnosing fetal chromosomal aneuploidy using genomic sequencing |
| US9260753B2 (en) | 2011-03-24 | 2016-02-16 | President And Fellows Of Harvard College | Single cell nucleic acid detection and analysis |
| US10876152B2 (en) | 2012-09-04 | 2020-12-29 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
| US20160040229A1 (en) | 2013-08-16 | 2016-02-11 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
| EP4036247B1 (de) | 2012-09-04 | 2024-04-10 | Guardant Health, Inc. | Verfahren zur detektion von seltenen mutationen und kopienzahlvariationen |
| US11913065B2 (en) | 2012-09-04 | 2024-02-27 | Guardent Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
| US10706957B2 (en) | 2012-09-20 | 2020-07-07 | The Chinese University Of Hong Kong | Non-invasive determination of methylome of tumor from plasma |
| US9732390B2 (en) | 2012-09-20 | 2017-08-15 | The Chinese University Of Hong Kong | Non-invasive determination of methylome of fetus or tumor from plasma |
| LT3354747T (lt) | 2012-09-20 | 2021-04-12 | The Chinese University Of Hong Kong | Neinvazinis naviko metilomos nustatymas iš plazmos |
| CN105190656B (zh) | 2013-01-17 | 2018-01-16 | 佩索纳里斯公司 | 用于遗传分析的方法和系统 |
| EP4567682A3 (de) | 2013-08-30 | 2025-09-03 | Personalis, Inc. | Verfahren zur genomanalyse |
| JP6295578B2 (ja) * | 2013-09-30 | 2018-03-20 | 凸版印刷株式会社 | 反応容器、核酸解析装置、および核酸解析方法 |
| WO2015051275A1 (en) | 2013-10-03 | 2015-04-09 | Personalis, Inc. | Methods for analyzing genotypes |
| SG10201804519RA (en) | 2013-12-28 | 2018-07-30 | Guardant Health Inc | Methods and systems for detecting genetic variants |
| LT4026917T (lt) * | 2014-04-14 | 2024-03-12 | Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd. | Ląstelių ar audinio žūties nustatymo arba iš audinio ar ląstelės gautos dnr kilmės nustatymo dnr metilinimo analizės būdu metodas ir rinkinys |
| TWI895765B (zh) * | 2014-07-18 | 2025-09-01 | 香港中文大學 | Dna混合物中之組織甲基化模式分析 |
| WO2016070131A1 (en) | 2014-10-30 | 2016-05-06 | Personalis, Inc. | Methods for using mosaicism in nucleic acids sampled distal to their origin |
| US11168351B2 (en) | 2015-03-05 | 2021-11-09 | Streck, Inc. | Stabilization of nucleic acids in urine |
| US20170145475A1 (en) | 2015-11-20 | 2017-05-25 | Streck, Inc. | Single spin process for blood plasma separation and plasma composition including preservative |
| AU2016370835B2 (en) * | 2015-12-17 | 2020-02-13 | Illumina, Inc. | Distinguishing methylation levels in complex biological samples |
| CN117174167A (zh) | 2015-12-17 | 2023-12-05 | 夸登特健康公司 | 通过分析无细胞dna确定肿瘤基因拷贝数的方法 |
| US11299783B2 (en) | 2016-05-27 | 2022-04-12 | Personalis, Inc. | Methods and systems for genetic analysis |
| EP3885447B1 (de) * | 2016-05-30 | 2024-01-10 | The Chinese University Of Hong Kong | Erkennung von hämatologischen erkrankungen unter verwendung von zellfreier dna im blut |
| CN116445593A (zh) | 2016-08-10 | 2023-07-18 | 格里尔公司 | 测定一生物样品的一甲基化图谱的方法 |
| WO2018064629A1 (en) | 2016-09-30 | 2018-04-05 | Guardant Health, Inc. | Methods for multi-resolution analysis of cell-free nucleic acids |
| US9850523B1 (en) | 2016-09-30 | 2017-12-26 | Guardant Health, Inc. | Methods for multi-resolution analysis of cell-free nucleic acids |
| EP3535415A4 (de) | 2016-10-24 | 2020-07-01 | The Chinese University of Hong Kong | Verfahren und systeme zur tumordetektion |
| IL315032A (en) | 2016-11-30 | 2024-10-01 | Univ Hong Kong Chinese | Analysis of cell-free dna in urine and other samples |
| CA3051509A1 (en) | 2017-01-25 | 2018-08-02 | The Chinese University Of Hong Kong | Diagnostic applications using nucleic acid fragments |
| EP3366780B1 (de) | 2017-02-23 | 2020-05-06 | Siemens Healthcare GmbH | Sequenzanalyse von einzelmolekülen und hochempfindliche methylierungsanalyse zur gewebespezifischen analyse |
| US11179516B2 (en) | 2017-06-22 | 2021-11-23 | Baxter International Inc. | Systems and methods for incorporating patient pressure into medical fluid delivery |
| JP7776099B2 (ja) | 2017-07-26 | 2025-11-26 | ザ チャイニーズ ユニバーシティー オブ ホンコン | 無細胞ウイルス核酸を用いる癌スクリーニングの強化 |
| EP4427588A3 (de) | 2017-10-19 | 2024-10-16 | Streck LLC | Zusammensetzungen zur hämolyse- und gerinnungsregulierung sowie stabilisierung von extrazellulären vesikeln |
| WO2019178277A1 (en) | 2018-03-13 | 2019-09-19 | Grail, Inc. | Anomalous fragment detection and classification |
| DE202019005627U1 (de) | 2018-04-02 | 2021-05-31 | Grail, Inc. | Methylierungsmarker und gezielte Methylierungssondenpanels |
| US10801064B2 (en) | 2018-05-31 | 2020-10-13 | Personalis, Inc. | Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples |
| US11814750B2 (en) | 2018-05-31 | 2023-11-14 | Personalis, Inc. | Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples |
| AU2019351130B2 (en) | 2018-09-27 | 2025-10-23 | GRAIL, Inc | Methylation markers and targeted methylation probe panel |
| WO2020132572A1 (en) | 2018-12-21 | 2020-06-25 | Grail, Inc. | Source of origin deconvolution based on methylation fragments in cell-free-dna samples |
| ES3013495T3 (en) | 2019-01-31 | 2025-04-14 | Guardant Health Inc | Method for isolating and sequencing cell-free dna |
| US11427874B1 (en) | 2019-08-26 | 2022-08-30 | Epi One Inc. | Methods and systems for detection of prostate cancer by DNA methylation analysis |
| CN114945987A (zh) | 2019-11-05 | 2022-08-26 | 佩索纳里斯公司 | 从单一样品预估肿瘤纯度 |
| EP4096694A4 (de) | 2020-01-30 | 2024-01-24 | Prognomiq Inc | Lungenbiomarker und verfahren zur verwendung davon |
| US12334190B2 (en) | 2021-03-31 | 2025-06-17 | PrognomIQ, Inc. | Multi-omic assessment using proteins and nucleic acids |
| WO2022256617A1 (en) | 2021-06-03 | 2022-12-08 | Inherent Biosciences, Inc. | Dna methylation analysis to identify cell type |
| US12387508B2 (en) | 2021-09-10 | 2025-08-12 | PrognomIQ, Inc. | Direct classification of raw biomolecule measurement data |
| EP4402473A4 (de) | 2021-09-13 | 2025-07-30 | Prognomiq Inc | Verbesserter nachweis und quantifizierung von biomolekülen |
| WO2023059654A1 (en) | 2021-10-05 | 2023-04-13 | Personalis, Inc. | Customized assays for personalized cancer monitoring |
| CN116042848B (zh) * | 2021-10-28 | 2024-08-09 | 北京干细胞与再生医学研究院 | 一种通过血样检测判断动物体内存在移植物的方法 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4897355A (en) * | 1985-01-07 | 1990-01-30 | Syntex (U.S.A.) Inc. | N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
| US4683195A (en) * | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US4683202A (en) * | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4800159A (en) * | 1986-02-07 | 1989-01-24 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences |
| EP0655090B1 (de) * | 1992-04-27 | 2000-12-27 | The Trustees Of Dartmouth College | Detektion von gensequenzen in biologischen flüssigkeiten |
| US6020124A (en) * | 1992-04-27 | 2000-02-01 | Trustees Of Dartmouth College | Detection of soluble gene sequences in biological fluids |
| US5538848A (en) * | 1994-11-16 | 1996-07-23 | Applied Biosystems Division, Perkin-Elmer Corp. | Method for detecting nucleic acid amplification using self-quenching fluorescence probe |
| CH686982A5 (fr) * | 1993-12-16 | 1996-08-15 | Maurice Stroun | Méthode pour le diagnostic de cancers. |
| US5552277A (en) * | 1994-07-19 | 1996-09-03 | The Johns Hopkins University School Of Medicine | Genetic diagnosis of prostate cancer |
| DE4441057C2 (de) * | 1994-11-17 | 1999-02-25 | Wacker Chemie Gmbh | Verfahren zur kontinuierlichen Herstellung von Organopolysiloxanen |
| AU693023B2 (en) * | 1995-05-05 | 1998-06-18 | Applied Biosystems, Llc | Methods and reagents for combined PCR amplification and hybridization probing assay |
| AU2324997A (en) * | 1996-03-15 | 1997-10-01 | Penn State Research Foundation, The | Detection of extracellular tumor-associated nucleic acid in blood plasma or ser um using nucleic acid amplification assays |
| US6017704A (en) * | 1996-06-03 | 2000-01-25 | The Johns Hopkins University School Of Medicine | Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids |
| EP0956365A4 (de) * | 1996-08-28 | 2004-08-25 | Univ Johns Hopkins Med | Verfahren zur detektion zellproliferativer deregulationen |
| US6251594B1 (en) * | 1997-06-09 | 2001-06-26 | Usc/Norris Comprehensive Cancer Ctr. | Cancer diagnostic method based upon DNA methylation differences |
| DE19754482A1 (de) * | 1997-11-27 | 1999-07-01 | Epigenomics Gmbh | Verfahren zur Herstellung komplexer DNA-Methylierungs-Fingerabdrücke |
| EP1052293B1 (de) * | 1999-05-12 | 2003-12-17 | Hamamatsu Photonics K.K. | Nachweis von Nukleinsäuren im Zytoplasma |
| US6331393B1 (en) * | 1999-05-14 | 2001-12-18 | University Of Southern California | Process for high-throughput DNA methylation analysis |
| JP2003534005A (ja) * | 2000-05-22 | 2003-11-18 | ザ ジョンズ ホプキンス ユニバーシティ | 遺伝子インプリンティングおよびメチル化ＣｐＧアイランドのアッセイ法 |
| US6927028B2 (en) * | 2001-08-31 | 2005-08-09 | Chinese University Of Hong Kong | Non-invasive methods for detecting non-host DNA in a host using epigenetic differences between the host and non-host DNA |
| US7045319B2 (en) * | 2001-10-30 | 2006-05-16 | Ribomed Biotechnologies, Inc. | Molecular detection systems utilizing reiterative oligonucleotide synthesis |
-
2002
- 2002-03-05 DK DK02004954T patent/DK1342794T3/da active
- 2002-03-05 DE DE60207979T patent/DE60207979T2/de not_active Expired - Lifetime
- 2002-03-05 AT AT02004954T patent/ATE312946T1/de active
- 2002-03-05 EP EP02004954A patent/EP1342794B1/de not_active Expired - Lifetime
- 2002-03-05 ES ES02004954T patent/ES2253461T3/es not_active Expired - Lifetime
-
2003
- 2003-03-05 AU AU2003218691A patent/AU2003218691B2/en not_active Expired
- 2003-03-05 US US10/506,693 patent/US20050221314A1/en not_active Abandoned
- 2003-03-05 EP EP03711926A patent/EP1483410A1/de not_active Withdrawn
- 2003-03-05 WO PCT/EP2003/002245 patent/WO2003074730A1/en not_active Ceased
- 2003-03-05 CA CA002478493A patent/CA2478493A1/en not_active Abandoned
- 2003-03-05 JP JP2003573175A patent/JP4727149B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003074730A1 (en) | 2003-09-12 |
| DK1342794T3 (da) | 2006-04-24 |
| JP2005518809A (ja) | 2005-06-30 |
| CA2478493A1 (en) | 2003-09-12 |
| JP4727149B2 (ja) | 2011-07-20 |
| EP1342794B1 (de) | 2005-12-14 |
| EP1483410A1 (de) | 2004-12-08 |
| AU2003218691B2 (en) | 2008-06-12 |
| EP1342794A1 (de) | 2003-09-10 |
| DE60207979D1 (de) | 2006-01-19 |
| US20050221314A1 (en) | 2005-10-06 |
| AU2003218691A1 (en) | 2003-09-16 |
| ES2253461T3 (es) | 2006-06-01 |
| DE60207979T2 (de) | 2006-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE312946T1 (de) | Verfahren und vorrichtung zur bestimmung der gewebespezifität von freier dna in körperflüssigkeiten | |
| WO2004046729A3 (en) | Bodily fluid markers of tissue hypoxia | |
| WO2006128192A3 (en) | Use of free circulating dna for diagnosis, prognosis, and treatment of cancer | |
| NO20030251L (no) | Fremgangsmåte for differensiering mellom biologiske tilstander basert på skjulte mönstre fra biologiske data | |
| DK1734368T3 (da) | Annexin-autoantistoffer anvendt som markörer for lungecancer | |
| CN104870997A (zh) | 诊断装置和方法 | |
| EP2306192A3 (de) | Risikomarker für eine Herzkreislaufkrankheit | |
| DE60239470D1 (de) | Verfahren zur bewertung pathologischer krankheitszustände unter verwendung extrazellulärer rna | |
| JP2010539490A5 (de) | ||
| ATE423217T1 (de) | Assays zur überwachung von krebspatienten auf grundlage der spiegel von analytenkomponenten des plasminogen-aktivator-systems in proben von körperflüssigkeiten | |
| ATE365922T1 (de) | Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6) | |
| EP1480251A3 (de) | Analyse komplexer Mischungen von biologischen und anderen Flüssigkeiten zur Erfassung ihrer Biologischen Eigenschaften. | |
| WO2002098280A3 (en) | Method for detecting infectious agents using computer controlled automated image analysis | |
| DE602005017519D1 (de) | Automatische glykofingerabdruck-strategie | |
| IL142971A0 (en) | S100 proteins and autoantibodies as serum markers for cancer | |
| WO2006119292A3 (en) | Methods for detection of biological substances | |
| WO2021038112A3 (en) | Apparatus and method for determination of banned substances | |
| RU2008103988A (ru) | Способ диагностики рассеяного склероза | |
| ATE408145T1 (de) | Verfahren zum nachweis von nierenkrankheiten und zur pathologischen überwachung | |
| EP1159614A4 (de) | Diagnostisches verfahren für asthma | |
| CA2623653A1 (en) | Use of n-myristoyltransferase on non-tumor tissue for cancer diagnosis | |
| ATE494556T1 (de) | Verfahren zur diagnose von entzündungserkrankungen und infektionen mittels bestimmung von lasp-1/ lap-1 | |
| EP1376133A4 (de) | Screening-verfahren für den prädiabetiszustand und screening-reagenz | |
| WO2020176569A1 (en) | Device for methods of detecting cancer | |
| KR102365475B1 (ko) | 신체 발톱의 케라틴 조직 중 중금속 프로파일링을 활용한 암진단 및 예후 바이오마커 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1342794 Country of ref document: EP |